Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis

Parasitology International

Volumn 53, Issue 4, 2004, Pages 315-325

  Dvorožňáková, Emília ^a   Hrčková, Gabriela ^a   Borošková, Zora ^a   Velebný, Samuel ^a   Dubinský, Pavol ^a  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

Author keywords

Albendazole; Echinococcus multilocularis; IFN ; IL 5; Liposomized albendazole; Superoxide anion; T and B lymphocytes

Indexed keywords

ALBENDAZOLE; GAMMA INTERFERON; INTERLEUKIN 5; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TH1 CELL; TREATMENT OUTCOME;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; B-LYMPHOCYTES; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; INTERFERON TYPE II; INTERLEUKIN-5; LIPOSOMES; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; SUPEROXIDES; T-LYMPHOCYTES; TREATMENT OUTCOME;

ECHINOCOCCUS; ECHINOCOCCUS MULTILOCULARIS;

EID: 4644224187     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2004.05.001     Document Type: Article

References (46)

1. Wilson J.F., Rausch R.L., Wilson F.R. Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos. Ann. Surg. 221:1995;315-323
2. Teggi A., Ladstilla G.M., De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob. Agents Chemother. 37:1993;1679-1687
3. El-On J. Benzimidazole treatment of cystic echinococcosis. Acta Trop. 85:2003;243-252
4. McManus D.P., Zhang W.B., Bartley P.B. Echinoccosis. Lancet. 362:2003;1295-1304
5. Bauder B., Auer H., Schilcher F., Gabler C., Romig T., Bilger B., et al. Experimental investigations on the B and T cell immune response in primary alveolar echinococcosis. Parasite Immunol. 21:1999;409-421
6. Vuitton D.A. The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop. 85:2003;119-132
7. Bresson-Hadni S., Vuitton D.A., Lenys D., Liance M., Racadot E., Miguet J.P. Cellular immune response in Echinococcus multicularis infections in humans: I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis. Clin. Exp. Immunol. 78:1989;61-66
8. Vuitton D.A., Bresson-Hadni S., Laroche L., Kaiserlian D., Guerret-Stocker S., Bresson J.L., et al. Cellular immune response in Echinococcus multilocularis infection in humans: II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin. Exp. Immunol. 78:1989;67-74
9. Emery I., Liance M., Deriaud E., Vuitton D.A., Houin R., Leclerc C. Characterization of T-cell immune responses of Echinococcus multilocularis- infected C57BL/6J mice. Parasite Immunol. 18:1996;463-472
10. Eckert J., Amman R.W. Clinical diagnosis and treatment of echinococcosis in human. Thompson R.C.A., Lymbery A.J. Echinococcus and hydatid disease. 1995;411-463 CAB International, Wallingford
11. Reuter S., Jensen B., Buttenschoen K., Kratzer W., Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother. 46:2000;451-456
12. Albendazole V.P. J. Antimicrob. Chemother. 41:1998;145-147
13. Capece B.P.S., Navarro M., Arcalis T., Castells G., Toribio L., Perez F., et al. Albendazole sulphoxide enantiomers in pregnant rats embryo concentrations and developmental toxicity. Vet. J. 165:2003;266-275
14. Gyurik R.J., Chow A.W., Zaber B., Brunner E.L., Miller J.A., Villani A.J., et al. Metabolism of albendazole in cattle, sheep, rats, and mice. Am. Soc. Pharmacol. Exp. Ther. 9:1981;503-508
15. Bogan J.A., Marriner S.E. Analysis of benzimidazoles in body fluids by high-performance liquid chromatography. J. Pharm. Sci. 69:1980;422-423
16. Schmid M., Samonigg H., Stoger H., Auer H., Sternthal M.H., Wilders-Truschnig M., et al. Use of interferon gamma and mebendazole to stop the progression of alvaolar hydatid disease: case report. Clin. Infect. Dis. 20:1995;1543-1546
17. Emery I., Leclerc C., Sengphommachanh K., Vuitton D.A., Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol. 20:1998;81-91
18. Papahadjopoulos D. Optimal liposomal drug action: from serendipity to targeting. Gregoriadis G. Liposome technology. vol. III:1992;1-14 CRC Press, Boca Raton
19. Alving C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods. 140:1991;315-323
20. Aramaki Y., Murai M., Tsuchiya S. Activation of Fc receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes. Pharm. Res. 11:1994;518-521
21. New R.R.C., Wen H., Craig P.S., Zou P.F., Merdan A., Wang J.H., et al. Efficacy of albendazole administered orally is improved by encapsulation in liposomes. J. Control. Release. 28:1994;350-352
22. Wen H., New R.R.C., Muhmut M., Wang J.H., Wang Y.H., Zhang J.H., et al. Pharmacologgy and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology. 113:1996;111-121
23. Velebný S., Tomašovičová O., Hrčkova G., Dubinský P. Toxocara canis in mice: are liposomes and immunomodulator able to enhance the larvicidal effect of anthelmintic? Helminthologia. 34:1997;147-153
24. Pagé M., Bejaouni N., Ciqo-Mars B., Lemieux P. Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol. 10:1988;785-793
25. Hrčkova G., Velebný S. Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology. 114:1997;475-482
26. Šoltýs J., Quinn M.T. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment β-(1,6)-branched β-(1,3)-glucan. Infect. Immun. 67:1999;244-252
27. Barta O., Bonner S.T., Shaffer L.M., Huang L.Y., Simmons L.A. Ascaris suum infection in pig sensitized lymphocytes but suppresses their responsiveness to phytomitogens. Vet. Parasitol. 21:1986;25-36
28. Borošková Z., Dvorožňáková E., Dubinský P., Velebný S., Tomašovičová O., Machnická B. Effect of free and liposomized albendazole on the immune response in healthy and Toxocara canis-infected mice. Vet. Med. Czech. 43:1998;293-300
29. Theodorides V.J., Gyurik R.J., Kingsbury W.D. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal round worms. Experientia. 32:1976;702-703
30. Pérez-Serrano J., Denegri G., Casado N., Rodríguez-Caabeiro F. In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary Echinococcosis in mice. Int. J. Parasitol. 27:1997;1341-1345
31. Bresson-Hadni S., Liance M., Meyer J.P., Houin R., Bresson J.L., Vuitton D.A. Cellular immunity in experimental Echinococcus multilocularis infection: II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin. Exp. Immunol. 82:1990;378-383
32. Alkarmi T.O., Ali-Khan Z. Chronic alveolar hydatidosis and secondary amyloidosis: pathological aspects of the disease in four strains of mice. Br. J. Exp. Pathol. 65:1984;405-417
33. Gottstein B., Wunderlin E., Tanner I. Echinococcus multicularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR., C57BL/6J) or resistant to secondary alveolar echinococcosis. Clin. Exp. Immunol. 96:1994;245-252
34. Joseph M. Effector functions of phagocytic cells against helminths. Clin. Immunol. Allergy. 2:1982;567-596
35. Alkarmi T.O., Alshakarchi Z., Behbehani K. Echinococcus multilocularis: the non-specific binding of different species of immunoglobulins to alveolar hydatid cysts grown in vivo and in vitro. Parasite Immunol. 10:1988;443-457
36. Kizaki T., Ishige M., Bingyan W., Day N.K., Good R.A., Onoe K. Generation of CD8+ suppressor T cells by protoscoleces of Echinococcus multilocularis in vitro. Immunology. 79:1993;412-417
37. Kizaki T., Ishige M., Kobayashi S., Bingyan W., Kumagai M., Day N.K., et al. Suppression of T-cell proliferation by CD8+ T cells induced in the presence of protoscolices of Echinococcus multilocularis in vitro. Infect. Immun. 61:1993;525-533
38. Arai K., Lee F., Miyajimia S., Miyatake N., Arai N., Yokata N. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:1990;783-836
39. Emery I., Liance M., Leclerc C. Secondary Echinococcus multilocularis infection in A/J mice: delayed metacestode development is associated with Th1 cytokine production. Parasite Immunol. 19:1997;493-503
40. Sturm D., Meenzel J., Gottstein B., Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect. Immun. 63:1995;1688-1697
41. Rakha N.K., Dixon J.B., Carter S.D., Craig P.S., Jenkins P., Folkard S. Echinococcus multilocularis antigens modify accessory cell function of macrophages. Immunology. 74:1991;652-656
42. Šoltýs J., Turčeková L'., deRycke P.H. The effect of Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia. 36:1999;25-30
43. Davies P.M. Macrophages. Dale M.M., Foreman J.C., Fan T.-P.D. Textbook of immunopharmacology. 1994;64-74 Blackwell, Oxford
44. Allen T.M. Interactions of liposomes and other drug carriers with the mononuclear phagocyte system. Gregoriadis G. Liposomes as drug carriers. Recent trends and progress. 1986;37-50 John Wiley & Sons, Chichester, NY
45. Straubinger R.M., Hong K., Friend D.S., Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with low pH compartment after internalization in coated vesicles. Cell. 32:1983;1069-1079
46. Badway J.A., Carnutte J.T., Robinson J.M., Berdes C.B., Karnovsky J., Karnovsky M.L. Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. J. Biol. Chem. 259:1984;7870-7877